Let's change the story for people living with obesity. Join Obesity Therapy Area - Novo Nordisk

(1:30)

🎉 ¡Año Nuevo Chino! Ana retoma sus propósito y lo intenta de nuevo 🐉✨

(28)

🎉 ¡Año Nuevo Chino! Ana retoma sus propósito y lo intenta de nuevo 🐉✨

(1:14)

Join us for a career within Manufacturing

(1:42)

Join us for a career within Engineering

(1:59)

Meet Brittany, Engineering a Rewarding Career in Manufacturing

(1:25)

Meet Charlene, Leaders on the Line in U.S. Manufacturing

(1:12)

Meet Matt, Military Veteran Turned Logistics Leader

(1:24)

Join us for a career within Supply Chain

(1:59)

Join us for a career within Project Management

(2:10)

Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly

(3:58)

Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook

(7:56)

Novo Nordisk CEO expects same growth for 2025

(3:1econd)

Отчетный ролик Novo Nordisk Фиасп \

(1:33)

“Ново Нордіск” – партнер України у відновленні країни та здоров’я людей

(3:32)

Novo Nordisk APX expansion

(1:50)

Danish Pharma Novo Nordisk Thrives in China, Showcasing Global Appeal

(2:1econd)

Join us in Novo Nordisk Manufacturing

(1:29)

$NVO Novo Nordisk Q4 2024 Earnings Conference Call

(1:11:21)

Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz

(2:53)

The effects of Ozempic and other weight loss injections | 60 Minutes Australia

(19:15)

Dans les coulisses de Novo Nordisk

(6:11)

RESULTADOS!!!! NOVO NORDISK, DISNEY, UBER!!!!!

(19:47)

Warum die Novo Nordisk Aktie JETZT besonders interessant ist!

(9:12)

NOVO NORDISK

(6:53)

How Ozempic is Currently Breaking the Stock Market (and Denmark’s Economy)

(11:23)

Novo Nordisk study shows Wegovy can cut heart attack and stroke risk

(1:29)

CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field

(4:8)

Alan Walker, K-391 \u0026 Emelie Hollow - Lily (Lyrics)

(3:16)

Bloomberg Turnaround: AstraZeneca

(24:7)

GSK – Our story

(3:57)

Commercial Video - Novo Nordisk Diabetes (PSA)

(1:1econd)

Join Novo Nordisk Manufacturing in the US

(1:29)

The CEO Behind Ozempic, Wegovy and Europe's Most Valuable Company

(24:7)

Wegovy sales double, but Novo Nordisk expects slower growth in 2025 | REUTERS

(1:16)

Novo Nordisk says Wegovy wins China approval | REUTERS

(1:3)

We are Team Novo Nordisk

(2:15)